Efficacy and Safety of Remdesivir in COVID-19 Positive Dialysis Patients

(1) Background: Immune compromised hemodialysis patients are more likely to develop COVID-19 infections, which increase the risk of mortality. The benefits of Remdesivir, despite less literature support on its effectiveness in dialysis patients due to renal toxicity, can outweigh the risks if prescr...

Descripción completa

Detalles Bibliográficos
Autores principales: Butt, Batool, Hussain, Tajamul, Jarrar, Mu’taman, Khalid, Kashaf, Albaker, Waleed, Ambreen, Asma, Waheed, Yasir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8868295/
https://www.ncbi.nlm.nih.gov/pubmed/35203759
http://dx.doi.org/10.3390/antibiotics11020156

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8868295/
https://www.ncbi.nlm.nih.gov/pubmed/35203759
http://dx.doi.org/10.3390/antibiotics11020156

Ejemplares similares